CSL's Seqirus caps off $156M expansion of flu manufacturing facility in Raleigh suburb

CSL's Seqirus caps off $156M expansion of flu manufacturing facility in Raleigh suburb

Source: 
Endpoints
snippet: 

The flu vaccine manufacturer Seqirus has completed a new facility expansion at its site in Holly Springs, NC, a suburb of Raleigh.

The expansion, which started in 2018, cost the company $156 million and will add around 80 jobs to the area. The expansion will also bring the Holly Springs site to a total of 664,000 square feet, according to the company.